New insights on the development of fungal vaccines: from immunity to recent challenges
AUTOR(ES)
Medici, Natasha P, Del Poeta, Maurizio
FONTE
Mem. Inst. Oswaldo Cruz
DATA DE PUBLICAÇÃO
24/11/2015
RESUMO
Fungal infections are emerging as a major problem in part due to high mortality associated with systemic infections, especially in the case of immunocompromised patients. With the development of new treatments for diseases such as cancer and the acquired immune deficiency syndrome pandemic, the number of immunosuppressed patients has increased and, as a consequence, also the number of invasive fungal infections has increased. Several studies have proposed new strategies for the development of effective fungal vaccines. In addition, better understanding of how the immune system works against fungal pathogens has improved the further development of these new vaccination strategies. As a result, some fungal vaccines have advanced through clinical trials. However, there are still many challenges that prevent the clinical development of fungal vaccines that can efficiently immunise subjects at risk of developing invasive fungal infections. In this review, we will discuss these new vaccination strategies and the challenges that they present. In the future with proper investments, fungal vaccines may soon become a reality.
Documentos Relacionados
- Challenges in the research and development of new human vaccines
- Toward a new generation of vaccines: The anti-cytokine therapeutic vaccines
- Modulation of delayed-type hypersensitivity and cellular immunity to microbial vaccines: effects of cyclophosphamide on the immune response to tularemia vaccine.
- Cancer vaccines: progress reveals new complexities
- Challenges to the development of antigen-specific breast cancer vaccines